Healthcare -
Biotechnology - NASDAQ - US
$ 10.14
-2.12 %
$ 764 M
Market Cap
-3.34
P/E
REPL - COMMON STOCK
Common Stock REPL - Replimune Group, Inc.
61 K
LAST VALUE
13.92%
2 YEAR CAGR
13.77%
5 YEAR CAGR
0.00%
10 YEAR CAGR